11BETA-13, 14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA
- CAS No.
- 107615-77-0
- Chemical Name:
- 11BETA-13, 14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA
- Synonyms
- VKTIONYPMSCHQI-KGILNJEGSA-N;11β-13,14-dihydro-15-keto Prostaglandin F2α;11β-13,14-dihydro-15-keto Prostaglandin F2α;11BETA-13, 14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA;9ALPHA, 11BETA-DIHYDROXY-15-OXO-PROST-5Z-EN-1-OIC ACID
- CBNumber:
- CB8213295
- Molecular Formula:
- C20H34O5
- Molecular Weight:
- 354.48
- MDL Number:
- MFCD00216071
- MOL File:
- 107615-77-0.mol
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS02,GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H225-H319-H336 | |||||||||
| Precautionary statements | P210-P240-P241-P242-P243-P261-P264-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P312-P337+P313-P370+P378-P403+P233-P403+P235-P405-P501 | |||||||||
| NFPA 704 |
|
11BETA-13, 14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA price More Price(5)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 16540 | 11β-13,14-dihydro-15-keto Prostaglandin F2α ≥95% | 107615-77-0 | 50μg | $57 | 2024-03-01 | Buy |
| Cayman Chemical | 16540 | 11β-13,14-dihydro-15-keto Prostaglandin F2α ≥95% | 107615-77-0 | 100μg | $107 | 2024-03-01 | Buy |
| Cayman Chemical | 16540 | 11β-13,14-dihydro-15-keto Prostaglandin F2α ≥95% | 107615-77-0 | 500μg | $437 | 2024-03-01 | Buy |
| American Custom Chemicals Corporation | SHG0004712 | 9ALPHA,11BETA-DIHYDROXY-15-OXO-PROST-5Z-EN-1-OIC ACID 98.00% | 107615-77-0 | 1MG | $1660.89 | 2021-12-16 | Buy |
| AHH | MT-09902 | 9alpha,11beta-Dihydroxy-15-oxo-prost-5Z-en-1-oicacid 98% | 107615-77-0 | 0.001g | $608 | 2021-12-16 | Buy |
11BETA-13, 14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA Chemical Properties,Uses,Production
Description
11β-13,14-dihydro-15-keto PGF2α is a metabolite of PGD2 in the 15-hydroxy PGDH pathway.1,2 Infusion or inhalation of tritiated PGD2 in normal males results in the appearance of peak levels of both 11β-PGF2α, as the immediate product, and 11β-13,14-dihydro-15-keto PGF2α in the plasma within 10 minutes.1 Homogenates of human lung metabolize PGD2 first to 11β-PGF2α and then to 11β-15-keto-PGF2α in the presence of NAD+, but not 11β-13,14-dihydro-15-keto PGF2α.2 Guinea pig liver and kidney homogenates metabolize PGD2 to 11β-13,14-dihydro-15-keto PGF2α, via 11β-PGF2α, in the presence of NAD+ and NADP+.2
Definition
ChEBI: 11beta-13,14-dihydro-15-keto-PGF2alpha is a prostanoid.
References
1. Robinson, C., Hardy, C.C., and Holgate, S.T. The metabolism of prostaglandin D2 after inhalation or intravenous infusion in normal men Biochim. Biophys. Acta 963(2),151-161(1988).
2. Robinson, C., Herbert, C.A., Bedwell, S., et al. The metabolism of prostaglandin D2. Evidence for the sequential conversion by NADPH and NAD+ dependent pathways Biochem. Pharmacol. 38(19),3267-3271(1989).
11BETA-13, 14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA Preparation Products And Raw materials
Raw materials
Preparation Products
11BETA-13, 14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9709 | 58 |
| Shanghai Hongye Biotechnology Co. Ltd | 400-9205774 | sales@glpbio.cn | China | 6870 | 58 |
| Hangzhou Synstar pharmaceutical Technology CO.,Ltd | 0571-85361029 | synstar518@163.com | China | 1991 | 58 |
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11289 | 58 |